SBI Securities
EIKN icon

SBI Securities’s Eikon Therapeutics EIKN Stock Holding History

SBI Securities’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16 Hold
2
– – ﹤0.01% 3954
2026
Q2 		$26 Buy
+2
New +$20 ﹤0.01% 3800

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

SBI Securities's EIKN Position: Q3 2026 in Review

SBI Securities held its Eikon Therapeutics (EIKN) position steady in Q3 2026 at 2 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #3954.

SBI Securities first reported a position in EIKN in Q2 2026 and has held it in 2 quarters since. The position peaked at $26 in Q2 2026. 46 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • SBI Securities held 2 shares of Eikon Therapeutics worth $16 as of Q3 2026.
  • SBI Securities left its Eikon Therapeutics share count unchanged in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3954 holding.
  • SBI Securities first reported a position in Eikon Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • SBI Securities's Eikon Therapeutics position peaked at $26 in Q2 2026.
  • 46 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.